These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 22223336)
21. The Staphylococcus aureus AirSR Two-Component System Mediates Reactive Oxygen Species Resistance via Transcriptional Regulation of Staphyloxanthin Production. Hall JW; Yang J; Guo H; Ji Y Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27872240 [TBL] [Abstract][Full Text] [Related]
22. Telavancin in vitro activity against a collection of methicillin-resistant Staphylococcus aureus isolates, including resistant subsets, from the United States. Mendes RE; Sader HS; Flamm RK; Farrell DJ; Jones RN Antimicrob Agents Chemother; 2015 Mar; 59(3):1811-4. PubMed ID: 25561335 [TBL] [Abstract][Full Text] [Related]
23. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model. Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524 [TBL] [Abstract][Full Text] [Related]
24. Alternative agents to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Culos KA; Cannon JP; Grim SA Am J Ther; 2013; 20(2):200-12. PubMed ID: 21642833 [TBL] [Abstract][Full Text] [Related]
26. A Computer-Driven Approach to Discover Natural Product Leads for Methicillin-Resistant Dias T; Gaudêncio SP; Pereira F Mar Drugs; 2018 Dec; 17(1):. PubMed ID: 30597893 [TBL] [Abstract][Full Text] [Related]
27. [Genotyping and drug resistance of methicillin-resistant Staphylococcus aureus]. Yao M; Guan L; Jia W; Wang L; Li G; Wu X; Sun T Zhonghua Shao Shang Za Zhi; 2014 Oct; 30(5):428-32. PubMed ID: 25572893 [TBL] [Abstract][Full Text] [Related]
28. Different formulations of vancomycin: In vitro antimicrobial activity against clinical isolates of methicillin-resistant Staphylococcus aureus. Fabri FV; Lolis MA; Gimenes M; Tognim MCB; Caparroz-Assef SM Diagn Microbiol Infect Dis; 2018 Dec; 92(4):332-337. PubMed ID: 30033164 [TBL] [Abstract][Full Text] [Related]
29. Emergence of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Clinical Isolates Among Daptomycin-Naive Patients in Korea. Nam EY; Yang SJ; Kim ES; Cho JE; Park KH; Jung SI; Yoon N; Kim DM; Lee CS; Jang HC; Park Y; Lee KS; Kwak YG; Lee JH; Park SY; Hwang JH; Kim M; Song KH; Kim HB Microb Drug Resist; 2018 Jun; 24(5):534-541. PubMed ID: 29863982 [TBL] [Abstract][Full Text] [Related]
30. Increasing levels of minimum inhibitory concentration vancomycin in methicillin resistant Staphylococcus aureus alarming bell for vancomycin abusers? Veer P; Chande C; Chavan S; Wabale V; Chopdekar K; Bade J; Joshi A Indian J Med Microbiol; 2010; 28(4):413-4. PubMed ID: 20966589 [No Abstract] [Full Text] [Related]
31. Methicillin resistant Staphylococcus aureus (MRSA) in Malwa region of Punjab (North-West India). Jindal N; Malhotra R; Grover P; Singh S; Bansal R; Kaur S Indian J Med Res; 2016 Mar; 143(3):371-2. PubMed ID: 27241653 [No Abstract] [Full Text] [Related]
32. Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal. Adhikari RP; Shrestha S; Barakoti A; Amatya R BMC Infect Dis; 2017 Jul; 17(1):483. PubMed ID: 28693489 [TBL] [Abstract][Full Text] [Related]
33. Vancomycin minimum inhibitory concentrations (MICs) for meticillin-resistant Staphylococcus aureus (MRSA) in Hong Kong. Ip M; Chau SS; Lui SL; Leung E; Ling T Int J Antimicrob Agents; 2010 Oct; 36(4):386-7. PubMed ID: 20702065 [No Abstract] [Full Text] [Related]